Doctors Tell Senate Pandemic Deaths Preventable With Early Treatments

November 19, 2020 by Tom Ramstack
Doctors Tell Senate Pandemic Deaths Preventable With Early Treatments
People stand in line to being tested at the COVID-19 mobile testing facility at Miami Beach Convention Center in Miami Beach, Fla. (David Santiago/Miami Herald via AP)

WASHINGTON — Medical experts told a Senate committee Thursday that misguided information about early treatment contributed to giving the United States the world’s highest death rate from coronavirus.

Some of them blamed the Food and Drug Administration for halting a treatment they say could have reduced the death toll far below the current rate that topped a quarter million this week.

“It’s grossly overlooked,” said Peter A. McCullough, vice chief of internal medicine at Baylor University Medical Center.

He recommended treating COVID-19 patients as soon as they show symptoms with a cocktail of cortical steroids, blood thinners and a controversial drug called Hydroxychloroquine.

“This cocktail of drugs works for sure,” said McCullough, who was infected with COVID-19 but recovered after taking Hydroxychloroquine.

He warned that waiting for vaccines that will become commonly available sometime in mid-2021 could be disastrous.

“In a matter of weeks to months, Americans are going to be horrified by what they see on the news,” McCullough told the Senate Homeland Security and Governmental Affairs Committee.

Some medical forecasts show another 100,000 Americans could die from the disease by January. More than 11.5 million Americans have been infected, according to Johns Hopkins University data.

Much of the controversy during the Senate hearing focused on the quality of scientific studies that either show Hydroxychloroquine is an effective treatment or potentially dangerous. Three medical experts said the studies show it is worthwhile while one said different data demonstrated it provided no benefit to patients.

President Donald Trump last Spring recommended Hydroxychloroquine as an early treatment for COVID-19. He said he was taking it himself as a preventive measure.

However, in July the Food and Drug Administration issued a warning that Hydroxychloroquine was a waste of time for COVID-19. The warning added that the inexpensive, readily-available drug could cause heart attacks with prolonged use.

Sen. Ron Johnson, R-Wisc., blamed politics rather than medical science as the barrier to early treatment with Hydroxychloroquine and other medicines. He called the failure of the Food and Drug Administration to authorize the treatments “this glaring blunder that has cost far too many lives.”

“There’s something wrong here,” Johnson said as he pledged to investigate further. He chairs the Homeland and Governmental Affairs Committee.

Johnson suggested the Food and Drug Administration might have issued its warning about Hydroxychloroquine partly because of opposition to Trump’s policies.

He also asked whether the relatively small cost of the drug at about $20 per dose might have created political pressure to suppress it. Other drugs produced by American pharmaceutical companies that are used to treat COVID-19 can cost as much as $3,000 per treatment, he said.

The strongest opposition to treatment with Hydroxychloroquine or anything other than the currently approved therapies came from Ashish K. Jha, dean of Brown University’s School of Public Health.

“Hydroxychloroquine provides no benefit in treating COVID-19,” Jha said.

Unscientific studies led to “conspiracy” theories that misled some doctors about the effectiveness of the drug, he said.

Until vaccines scheduled for widespread distribution next year become available, he suggested standard prevention methods. They include wearing masks, social distancing, opening windows for fresh air and cleanliness.

He tried to debunk disputes over Hydroxychloroquine by saying they were driven by political disagreement rather than confusion over scientific studies reviewed by thousands of doctors.

“Pulling off a conspiracy like that would be extremely difficult,” Jha said.

A+
a-
  • Coronavirus
  • Food and Drug Administration
  • hydroxychloroquine
  • preventable deaths
  • Senate
  • In The News

    Health

    Voting

    Health

    Biden Announcing New Rule to Protect Consumers Who Purchase Short-Term Health Insurance Plans

    President Joe Biden on Thursday announced new steps to protect consumers who buy short-term health insurance plans that critics say amount to junk. A... Read More

    President Joe Biden on Thursday announced new steps to protect consumers who buy short-term health insurance plans that critics say amount to junk. A new rule finalized by the Democratic president's administration will limit these plans to just three months. And the plans can only be renewed for a maximum... Read More

    March 27, 2024
    by Dan McCue
    One-Time Treatment Could Revitalize Immune Systems in the Elderly

    PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of... Read More

    PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of immune cell could potentially revitalize the immune systems of the elderly, helping their bodies better react to viral and bacterial threats. The research was carried out... Read More

    March 27, 2024
    by Dan McCue
    Insurers to Expand Access to ‘Navigation Services’ for Cancer Patients

    WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients... Read More

    WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients and their families navigate the myriad challenges that might arise during treatment for cancer and other serious illnesses. The insurers involved are Aetna; Blue Cross Blue... Read More

    Five Takeaways From the Abortion Pill Case Before US Supreme Court

    WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone,... Read More

    WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration. It's... Read More

    Biden and Harris Argue Democrats Will Preserve Health Care and Republicans Would Take It Away

    RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in... Read More

    RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in the battleground state of North Carolina, arguing that Democrats like themselves would preserve access to care while Republicans would reverse gains made over the past decade... Read More

    March 26, 2024
    by Tom Ramstack
    Supreme Court Skeptical of Ban on Abortion Pill Mifepristone

    WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access... Read More

    WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access to the abortion pill mifepristone despite objections from anti-abortion activists. The doctors and organizations who sued argued the Food and Drug Administration was wrong in granting... Read More

    News From The Well
    scroll top